Necdin shapes serotonergic development and SERT activity modulating breathing in a mouse model for Prader-Willi Syndrome

  1. Valéry Matarazzo  Is a corresponding author
  2. Laura Caccialupi
  3. Fabienne Schaller
  4. Yuri Shvarev
  5. Nazim Kourdougli
  6. Alessandra Bertoni
  7. Clément Menuet
  8. Nicolas Voituron
  9. Evan Deneris
  10. Patricia Gaspar
  11. Laurent Bezin
  12. Pascale Durbec
  13. Gérard Hilaire
  14. Françoise Muscatelli  Is a corresponding author
  1. Institut de Neurobiologie de la Méditerranée, France
  2. Karolinska Institutet, Sweden
  3. UFR STAPS, Université Paris 13, France
  4. Case Western Reserve University, United States
  5. INSERM, U839, Institut du Fer à Moulin, France
  6. Lyon Neuroscience Research Center, France
  7. Aix Marseille University CNRS, France

Abstract

Prader-Willi syndrome (PWS) is a genetic neurodevelopmental disorder that presents with hypotonia and respiratory distress in neonates. The Necdin-deficient mouse is the only model that reproduces the respiratory phenotype of PWS (central apnea and blunted response to respiratory challenges). Here, we report that Necdin deletion disturbs the migration of serotonin (5-HT) neuronal precursors, leading to altered global serotonergic neuroarchitecture and increased spontaneous firing of 5-HT neurons. We show an increased expression and activity of 5-HT Transporter (SERT/Slc6a4) in 5-HT neurons leading to an increase of 5-HT uptake. In Necdin-KO pups, the genetic deletion of Slc6a4 or treatment with Fluoxetine, a 5-HT reuptake inhibitor, restored normal breathing. Unexpectedly, Fluoxetine administration was associated with respiratory side effects in wild-type animals. Overall, our results demonstrate that an increase of SERT activity is sufficient to cause the apneas in Necdin-KO pups, and that Fluoxetine may offer therapeutic benefits to PWS patients with respiratory complications.

Article and author information

Author details

  1. Valéry Matarazzo

    INSERM U901, Institut de Neurobiologie de la Méditerranée, Marseille, France
    For correspondence
    valery.matarazzo@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0833-203X
  2. Laura Caccialupi

    INSERM U901, Institut de Neurobiologie de la Méditerranée, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Fabienne Schaller

    INSERM U901, Institut de Neurobiologie de la Méditerranée, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Yuri Shvarev

    Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6622-1453
  5. Nazim Kourdougli

    INSERM U901, Institut de Neurobiologie de la Méditerranée, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8725-792X
  6. Alessandra Bertoni

    INSERM U901, Institut de Neurobiologie de la Méditerranée, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Clément Menuet

    INSERM U901, Institut de Neurobiologie de la Méditerranée, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7419-6427
  8. Nicolas Voituron

    UFR STAPS, Université Paris 13, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2092-4900
  9. Evan Deneris

    Department of Neurosciences, Case Western Reserve University, Cleveland, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Patricia Gaspar

    INSERM, U839, Institut du Fer à Moulin, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4217-5717
  11. Laurent Bezin

    CNRS, Lyon Neuroscience Research Center, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  12. Pascale Durbec

    IBDM UMR7288, Aix Marseille University CNRS, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9660-1809
  13. Gérard Hilaire

    INSERM U901, Institut de Neurobiologie de la Méditerranée, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  14. Françoise Muscatelli

    INSERM U901, Institut de Neurobiologie de la Méditerranée, Marseille, France
    For correspondence
    francoise.muscatelli@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4001-6528

Funding

Institut National de la Santé et de la Recherche Médicale

  • Valéry Matarazzo
  • Laura Caccialupi
  • Fabienne Schaller
  • Nazim Kourdougli
  • Alessandra Bertoni
  • Clément Menuet
  • Patricia Gaspar
  • Françoise Muscatelli

Centre National de la Recherche Scientifique

  • Laurent Bezin
  • Pascale Durbec
  • Gérard Hilaire
  • Françoise Muscatelli

Agence Nationale de la Recherche (PRAGEDER ANR14-CE13-0025-01)

  • Valéry Matarazzo
  • Fabienne Schaller
  • Yuri Shvarev
  • Clément Menuet
  • Nicolas Voituron
  • Gérard Hilaire
  • Françoise Muscatelli

Stiftelsen Frimurare Barnhuset i Stockholm

  • Yuri Shvarev

Kronprinsessan Lovisas Forening for Barnasjukvard

  • Yuri Shvarev

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Mice were handled and cared for in accordance with the Guide for the Care and Use of Laboratory Animals (N.R.C., 1996) and the European Communities Council Directive of September 22th 2010 (2010/63/EU, 74). Experimental protocols were approved by the Institutional Ethical Committee guidelines for animal research with the accreditation no. B13-055-19 from the French Ministry of Agriculture.

Copyright

© 2017, Matarazzo et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,388
    views
  • 253
    downloads
  • 28
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Valéry Matarazzo
  2. Laura Caccialupi
  3. Fabienne Schaller
  4. Yuri Shvarev
  5. Nazim Kourdougli
  6. Alessandra Bertoni
  7. Clément Menuet
  8. Nicolas Voituron
  9. Evan Deneris
  10. Patricia Gaspar
  11. Laurent Bezin
  12. Pascale Durbec
  13. Gérard Hilaire
  14. Françoise Muscatelli
(2017)
Necdin shapes serotonergic development and SERT activity modulating breathing in a mouse model for Prader-Willi Syndrome
eLife 6:e32640.
https://doi.org/10.7554/eLife.32640

Share this article

https://doi.org/10.7554/eLife.32640

Further reading

    1. Genetics and Genomics
    2. Neuroscience
    Tanya Wolff, Mark Eddison ... Gerald M Rubin
    Research Article

    The central complex (CX) plays a key role in many higher-order functions of the insect brain including navigation and activity regulation. Genetic tools for manipulating individual cell types, and knowledge of what neurotransmitters and neuromodulators they express, will be required to gain mechanistic understanding of how these functions are implemented. We generated and characterized split-GAL4 driver lines that express in individual or small subsets of about half of CX cell types. We surveyed neuropeptide and neuropeptide receptor expression in the central brain using fluorescent in situ hybridization. About half of the neuropeptides we examined were expressed in only a few cells, while the rest were expressed in dozens to hundreds of cells. Neuropeptide receptors were expressed more broadly and at lower levels. Using our GAL4 drivers to mark individual cell types, we found that 51 of the 85 CX cell types we examined expressed at least one neuropeptide and 21 expressed multiple neuropeptides. Surprisingly, all co-expressed a small molecule neurotransmitter. Finally, we used our driver lines to identify CX cell types whose activation affects sleep, and identified other central brain cell types that link the circadian clock to the CX. The well-characterized genetic tools and information on neuropeptide and neurotransmitter expression we provide should enhance studies of the CX.

    1. Neuroscience
    Roshani Nhuchhen Pradhan, Craig Montell, Youngseok Lee
    Research Article

    The question as to whether animals taste cholesterol taste is not resolved. This study investigates whether the fruit fly, Drosophila melanogaster, is capable of detecting cholesterol through their gustatory system. We found that flies are indifferent to low levels of cholesterol and avoid higher levels. The avoidance is mediated by gustatory receptor neurons (GRNs), demonstrating that flies can taste cholesterol. The cholesterol-responsive GRNs comprise a subset that also responds to bitter substances. Cholesterol detection depends on five ionotropic receptor (IR) family members, and disrupting any of these genes impairs the flies' ability to avoid cholesterol. Ectopic expressions of these IRs in GRNs reveals two classes of cholesterol receptors, each with three shared IRs and one unique subunit. Additionally, expressing cholesterol receptors in sugar-responsive GRNs confers attraction to cholesterol. This study reveals that flies can taste cholesterol, and that the detection depends on IRs in GRNs.